{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_6232", "batch_size": 200, "batch_pos": 73, "statement_text": "In a previous briefing, O'Connell said her agency was also negotiating with Pfizer for an mRNA vaccine against H5N1.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment uses neutral/procedural language ('negotiating') without high-potency verbs or metaphors.", "method": "llm_batch", "batch_id": "batch_2_15508", "batch_size": 200, "batch_pos": 63, "statement_text": "In a previous briefing, O'Connell said her agency was also negotiating with Pfizer for an mRNA vaccine against H5N1.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment discusses negotiations but does not use a moderate verb paired with scale or impact.", "method": "llm_batch", "batch_id": "batch_3_16616", "batch_size": 200, "batch_pos": 34, "statement_text": "In a previous briefing, O'Connell said her agency was also negotiating with Pfizer for an mRNA vaccine against H5N1.", "article_id": 1745}
